<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Lee+Yoon+Kwang&amp;sort_field=Dublin+Core%2CTitle&amp;sort_dir=a&amp;output=omeka-xml" accessDate="2026-03-14T19:09:37-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="6278" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="77213">
              <text>&lt;a href="http://doi.org/10.1016/j.molmet.2018.01.005" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.1016/j.molmet.2018.01.005&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Rights</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="77214">
              <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="77215">
              <text>131-140</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="77216">
              <text>9</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77205">
                <text>Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="77206">
                <text>Molecular metabolism</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77207">
                <text>2018</text>
              </elementText>
              <elementText elementTextId="77208">
                <text>2018-03</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77209">
                <text>Humans; Male; Animals; Mice; *Atherosclerosis; *Farnesoid X receptor; *NAFLD; *Obesity; *TGR5; Diet; Hep G2 Cells; Receptors; Inbred C57BL; High-Fat/adverse effects; Cytoplasmic and Nuclear/*agonists; Bile Acids and Salts/pharmacology/*therapeutic use; Hypercholesterolemia/*drug therapy/etiology/metabolism; Non-alcoholic Fatty Liver Disease/*drug therapy/etiology/metabolism; Obesity/*drug therapy/etiology/metabolism; G-Protein-Coupled/*agonists</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77210">
                <text>Jadhav Kavita; Xu Yang; Xu Yanyong; Li Yuanyuan; Xu Jiesi; Zhu Yingdong; Adorini Luciano; Lee Yoon Kwang; Kasumov Takhar; Yin Liya; Zhang Yanqiao</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="77211">
                <text>OBJECTIVES: Activation of the bile acid (BA) receptors farnesoid X receptor (FXR) or G protein-coupled bile acid receptor (GPBAR1; TGR5) improves metabolic homeostasis. In this study, we aim to determine the impact of pharmacological activation of bile acid receptors by INT-767 on reversal of diet-induced metabolic disorders, and the relative contribution of FXR vs. TGR5 to INT-767's effects on metabolic parameters. METHODS: Wild-type (WT), Tgr5(-/-), Fxr(-/-), Apoe(-/-) and Shp(-/-) mice were used to investigate whether and how BA receptor activation by INT-767, a semisynthetic agonist for both FXR and TGR5, could reverse diet-induced metabolic disorders. RESULTS: INT-767 reversed HFD-induced obesity dependent on activation of both TGR5 and FXR and also reversed the development of atherosclerosis and non-alcoholic fatty liver disease (NAFLD). Mechanistically, INT-767 improved hypercholesterolemia by activation of FXR and induced thermogenic genes via activation of TGR5 and/or FXR. Furthermore, INT-767 inhibited several lipogenic genes and de novo lipogenesis in the liver via activation of FXR. We identified peroxisome proliferation-activated receptor gamma (PPARgamma) and CCAAT/enhancer-binding protein alpha (CEBPalpha) as novel</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="77212">
                <text>&lt;a href="http://doi.org/10.1016/j.molmet.2018.01.005" target="_blank" rel="noreferrer noopener"&gt;10.1016/j.molmet.2018.01.005&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="24336">
        <name>*Atherosclerosis</name>
      </tag>
      <tag tagId="24337">
        <name>*Farnesoid X receptor</name>
      </tag>
      <tag tagId="23735">
        <name>*NAFLD</name>
      </tag>
      <tag tagId="23447">
        <name>*Obesity</name>
      </tag>
      <tag tagId="24338">
        <name>*TGR5</name>
      </tag>
      <tag tagId="275">
        <name>2018</name>
      </tag>
      <tag tagId="1503">
        <name>Adorini Luciano</name>
      </tag>
      <tag tagId="123">
        <name>Animals</name>
      </tag>
      <tag tagId="33052">
        <name>Bile Acids and Salts/pharmacology/*therapeutic use</name>
      </tag>
      <tag tagId="27120">
        <name>Cytoplasmic and Nuclear/*agonists</name>
      </tag>
      <tag tagId="32956">
        <name>Department of Integrative Medical Sciences</name>
      </tag>
      <tag tagId="32950">
        <name>Department of Pharmaceutical Sciences</name>
      </tag>
      <tag tagId="104">
        <name>Diet</name>
      </tag>
      <tag tagId="33056">
        <name>G-Protein-Coupled/*agonists</name>
      </tag>
      <tag tagId="10082">
        <name>Hep G2 Cells</name>
      </tag>
      <tag tagId="1516">
        <name>High-Fat/adverse effects</name>
      </tag>
      <tag tagId="8">
        <name>Humans</name>
      </tag>
      <tag tagId="33053">
        <name>Hypercholesterolemia/*drug therapy/etiology/metabolism</name>
      </tag>
      <tag tagId="860">
        <name>Inbred C57BL</name>
      </tag>
      <tag tagId="1502">
        <name>Jadhav Kavita</name>
      </tag>
      <tag tagId="1522">
        <name>Kasumov Takhar</name>
      </tag>
      <tag tagId="1489">
        <name>Lee Yoon Kwang</name>
      </tag>
      <tag tagId="1498">
        <name>Li Yuanyuan</name>
      </tag>
      <tag tagId="24">
        <name>Male</name>
      </tag>
      <tag tagId="861">
        <name>Mice</name>
      </tag>
      <tag tagId="7897">
        <name>Molecular metabolism</name>
      </tag>
      <tag tagId="32953">
        <name>NEOMED College of Medicine</name>
      </tag>
      <tag tagId="32954">
        <name>NEOMED College of Pharmacy</name>
      </tag>
      <tag tagId="33054">
        <name>Non-alcoholic Fatty Liver Disease/*drug therapy/etiology/metabolism</name>
      </tag>
      <tag tagId="33055">
        <name>Obesity/*drug therapy/etiology/metabolism</name>
      </tag>
      <tag tagId="551">
        <name>Receptors</name>
      </tag>
      <tag tagId="1497">
        <name>Xu Jiesi</name>
      </tag>
      <tag tagId="1499">
        <name>Xu Yang</name>
      </tag>
      <tag tagId="5589">
        <name>Xu Yanyong</name>
      </tag>
      <tag tagId="1500">
        <name>Yin Liya</name>
      </tag>
      <tag tagId="1504">
        <name>Zhang Yanqiao</name>
      </tag>
      <tag tagId="7898">
        <name>Zhu Yingdong</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
